New spin out from leading UK University. Worked with investors and newly formed team to review and develop therapeutic antibody opportunity and strategy (Target Product Profile), followed by development and set-up of an operationally efficient drug discovery plan designed to deliver therapeutic entity.

Drug discovery team in place, operational drug discovery activities now active.